Estudio multicéntrico observacional de la mascarilla Ambu® AuraGain® en pacientes adultos |
| |
| Authors: | M Zaballos F Escribá S López J Zaballos J Montero I Fernández AM López |
| |
| Institution: | 1. Departamento de Toxicología, Universidad Complutense de Madrid, Madrid, España;2. Departamento de Anestesia, Hospital Universitario y Politécnico La Fe, Valencia, España;3. Departamento de Anestesia, Hospital Universitario Complejo A Coruña, Coruña, España;4. Departamento de Anestesia Policlínica, Quirón Grupo Salud, San Sebastián, España;5. Departamento de Anestesia, Hospital Universitario Vall d?Hebron, Barcelona, España;6. Departamento de Anestesia, Hospital General Universitario Gregorio Marañón, Madrid, España;7. Anestesiología y Algología, KU Leuven, Leuven, Bélgica;8. Departamento de Anestesia, Hospital Clinic de Barcelona, Barcelona, España;1. Servicio de Anestesiología, Centro Hospitalar Universitario Sao Joao, Porto, Portugal;2. MEDCIDS, Departamento de Medicina da Comunidad, Información y Decisión en Salud, Facultad de Medicina de Universidad de Porto, Porto, Portugal;3. Facultad de Medicina de Universidad de Porto, Porto, Portugal;4. Departamento de Cirugía y Fisiología, Facultad de Medicina de Universidad de Porto, Porto, Portugal;1. Departamento de Anestesia, Hospital de Niños Dr. Orlando Alassia, San José del Rincón, Santa Fe, Argentina;2. Department of Anesthesia, University of Mac Master, Hamilton, Canadá;3. Departamento de Anestesia, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay;1. Servicio de Anestesiología, Reanimación y Tratamiento del Dolor, Hospital General Universitario de Valencia, Valencia, España;2. Enfermería, Hospital General Universitario de Valencia, Valencia, España;3. Facultad de Medicina, Universitat de València, Valencia, España;1. Servicio de Anestesiología y Reanimación, Hospital Clínico Universitario de Valladolid, Valladolid, España;2. Servicio de Anestesiología y Reanimación, Hospital de Medina del Campo, Medina del Campo, Valladolid, España |
| |
| Abstract: | PurposeThe main objective of this study was to evaluate the performance of the Ambu? AuraGain? device by determining its main parameters of use and complications.MethodsA total of 250 adult ASA physical status i to iii patients from five hospitals in Spain who received general anaesthesia with a supraglottic airway (SGA) device were enrolled in this study.ResultsThe primary outcome was analysed for 244 patients and a median OLP of 32 cm H2O (IQR 28-36 cm H2O) was obtained. Insertion was achieved at first attempt in 85% of cases, and overall in 98% of cases, in a median time of 15 s (12-22.5). We applied manoeuvres in 61% of patients to facilitate the process. Ventilation was effective in 97.2% of the interventions (95% CI 0.99-0.94) throughout the procedure. Insertion of the gastric tube was easily performed in 99.6% of the patients, and the vocal cords were viewed by fibrobronchoscopy in 96.3% of cases. Logistic regression analysis identified the use of sizes smaller than those recommended as a risk factor for low OLP (< 25 cm H2O). The main complication recorded was the presence of blood when withdrawing the SGA device (15%).ConclusionsOur results confirm that the use of AuraGain allows airway management in a reliable and effective way achieving high OLP and low incidence of associated complications, establishing it as a useful alternative in the routine clinical setting of anaesthesiologists. AuraGain performance was consistent in all five centres. |
| |
| Keywords: | Supraglottic airway devices Ambu AuraGain Multicentric Oropharyngeal leak pressure |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
